The Perfect Enemy | Category: Social Impact | Page 298
September 19, 2025

Social Impact

Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests (“2.0”) under CE Mark for self-test and professional use

F. Hoffmann-La Roche LtdBroad and trusted portfolio of COVID-19 rapid tests feature innovative updates and enhanced performance, building on insights...